
浏览全部资源
扫码关注微信
浙江中医药大学附属第三医院,杭州 310005
浙江中医药大学第三临床医学院,杭州 310053
浙江中医药大学附属第一医院
✉马睿杰,教授。E-mail:719229866@qq.com
收稿:2024-03-22,
网络首发:2025-03-03,
纸质出版:2025-05-12
移动端阅览
周杰, 郑梦怡, 陈姗, 等. 电针“骶四穴”治疗轻中度良性前列腺增生伴下尿路症状:随机对照试验[J]. 中国针灸, 2025,45(5):627-632.
ZHOU Jie, ZHENG Mengyi, CHEN Shan, et al. Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2025, 45(5): 627-632.
周杰, 郑梦怡, 陈姗, 等. 电针“骶四穴”治疗轻中度良性前列腺增生伴下尿路症状:随机对照试验[J]. 中国针灸, 2025,45(5):627-632. DOI: 10.13703/j.0255-2930.20240322-k0003.
ZHOU Jie, ZHENG Mengyi, CHEN Shan, et al. Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2025, 45(5): 627-632. DOI: 10.13703/j.0255-2930.20240322-k0003.
目的:
2
观察电针“骶四穴”治疗轻中度良性前列腺增生伴下尿路症状的临床疗效。
方法:
2
将58例轻中度前列腺增生伴下尿路症状患者随机分为骶四穴电针组(29例,脱落1例)和常规电针组(29例,脱落1例)。骶四穴电针组予电针双侧骶尾关节旁开0.5寸处及会阳穴,常规电针组予电针关元、中极、曲骨及双侧水道、三阴交、足三里,两组均予连续波,频率2 Hz,每次30 min,隔日1次,每周3次,共治疗4周。分别于治疗前、治疗2、4周后及治疗后1个月(随访)时评价两组患者国际前列腺症状评分(IPSS)、膀胱过度活动症评分(OABSS)及生活质量指数(QOL)评分,于治疗前后经腹部B超测定前列腺体积(PV),并于治疗后评定两组临床疗效。
结果:
2
与治疗前比较,两组患者治疗4周后及随访时IPSS、OABSS及QOL评分降低(
P
<
0.01,
P
<
0.05)。骶四穴电针组患者治疗4周后及随访时IPSS和QOL评分低于常规电针组(
P
<
0.05,
P
<
0.01),随访时OABSS评分低于常规电针组(
P
<
0.05);骶四穴电针组患者治疗4周后和随访时IPSS、OABSS评分较治疗前降低幅度大于常规电针组(
P
<
0.01,
P
<
0.05),治疗2、4周后和随访时QOL评分较治疗前降低幅度大于常规电针组(
P
<
0.01)。治疗后,两组患者PV比较差异无统计学意义(
P
>
0.05)。骶四穴电针组总有效率为75.0%(21/28),高于常规电针组的39.3%(11/28,
P
<
0.01)。
结论:
2
电针“骶四穴”可有效改善轻中度前列腺增生患者下尿路症状、膀胱过度活动症状和生活质量,具有较好的近期及远期疗效,但不能减小前列腺体积。
Objective
2
To observe the clinical efficacy of electroacupuncture (EA) at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS).
Methods
2
A total of 58 patients with BPH/LUTS were randomly divided into a sacral four-point EA group (29 cases
1 case dropped out) and a conventional EA group (29 cases
1 case dropped out). EA was applied at bilateral points 0.5
cun
lateral to the sacrococcygeal joint and Huiyang (BL35) in the sacral four-point EA group; and was applied at Guanyuan (CV4)
Zhongji (CV3)
Qugu (CV2) and bilateral Shuidao (ST28)
Sanyinjiao (SP6)
Zusanli (ST36) in the conventional EA group. Both groups received continuous wave
2 Hz in frequency
30 min a time
once every other day
3 times a week for 4 weeks. Before treatment
after 2 and 4 weeks of treatment
and in follow-up of 1 month after treatment completion
the international prostate symptom score (IPSS)
the overactive bladder symptom score (OABSS)
the quality of life (QOL) score were observed; before and after treatment
the prostate volume (PV) was measured by abdominal ultrasound; and the clinical efficacy was evaluated after treatment in the two groups.
Results
2
Compared before treatment
the scores of IPSS
OABSS and QOL were decreased after 4 weeks of treatment and in follow-up in both groups (
P
<
0.01
P
<
0.05). In the sacral four-point EA group
the scores of IPSS and QOL after 4 weeks of treatment and in follow-up were lower than those in the conventional EA group (
P
<
0.05
P
<
0.01)
and the OABSS score in follow-up was lower than that in the conventional EA group (
P
<
0.05). After 4 weeks of treatment and in follow-up
the reductions of IPSS and OABSS scores compared before treatment in the sacral four-point EA group were larger than those in the conventional EA group (
P
<
0.01
P
<
0.05); After 2
4 weeks of treatment and in follow-up
the reductions of QOL score compared before treatment in the sacral four-point EA group were larger than those in the conventional EA group (
P
<
0.01). No significant difference in PV was observed after treatment between the two groups (
P
>
0.05). The total effective rate was 75.0% (21/28) in the sacral four-point EA group
which was higher than 39.3% (11/28) in the conventional EA group (
P
<
0.01).
Conclusion
2
EA at "four points of sacral region" can effectively improve the LUTS
overactive bladder symptom and quality of life in patients with mild-to-moderate BPH
and has good short-term and long-term efficacy
although it can not reduce prostate volume.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621